PLEGRIDY (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program

What is the PLEGRIDY Study?

The purpose of this observational study is to identify the long-term safety and effectiveness of PLEGRIDY, over approximately a five-year time period. Information on quality of life, side effects, relapses, and disability progression in patients taking PLEGRIDY will be collected. You do not need to come to the clinic for any extra visits as you will see your doctor as part of your regular care. Your participation in the study is voluntary.

Study Investigators: Dr. Teresa DeAngelis and Dr. Richard Blanck
ClinicalTrials.gov Identifier: NCT02230969
Link for more information: https://clinicaltrials.gov/ct2/show/NCT02230969?term=NCT02230969&rank=1